Berberine phytosome and liposomal berberine: what the absorption studies measured
A phytosome binds berberine to phospholipids, fats similar to those in cell membranes, to help absorption. In a study by staff of the maker of one berberine phytosome, total blood exposure to berberine in 12 healthy volunteers was about four times higher with one tablet, or 9.76 times higher after adjusting for berberine content.[1] None of the studies cited here measured a liposomal berberine product in people.
What each study measured
| Study | Who | Product | What was measured |
|---|---|---|---|
| Petrangolini 2021 | 12 healthy volunteers | 500 mg berberine chloride (452 mg berberine) or one or two 550 mg phytosome tablets (188 mg berberine per tablet) | For one tablet, total blood exposure about four times higher, or 9.76 times after adjusting for berberine content; no side effects observed[1] |
| Rondanelli 2021 | 12 women with polycystic ovary syndrome, no control group | Phospholipid berberine complex with lecithin, pea protein and grape seed extract, 2 tablets of 550 mg a day for 60 days; 550 mg is the tablet, not the berberine[2] | Lower insulin resistance score, inflammation markers, triglycerides, testosterone and body fat; liver and kidney tests unchanged[2] |
How much weight to give these results
- Who ran them. Authors of both studies include staff of Indena, the company that makes Berberine Phytosome. In the second study the women also received dietary counselling; Indena supplied the tablets, three authors were affiliated with the company, and the paper reports no external funding.[1][2]
- Blood levels are not an outcome. This pharmacokinetic result does not establish greater clinical benefit, and it applies to that formulation, not to all phytosomes or to liposomal products.[1]
- No comparison group in the second study. All 12 women took the product, so the changes cannot be separated from time or other factors.[2]
- Why forms matter at all. Regular berberine taken by mouth is broken down heavily in the gut wall and liver.[3]
Comparing labels
A phytosome label lists the weight of the berberine–phospholipid complex, which is not the same as milligrams of berberine HCl. Check whether the label states berberine content separately. For other forms, see dihydroberberine and how much berberine to take.
Information, not a prescription. Do not start, stop or combine supplements or medicines on your own.
More about berberine
- Berberine guide
- Berberine side effects: what studies and NCCIH report
- Does berberine help weight loss? What the trials measured
- Do berberine patches work? What has been tested
- What is dihydroberberine, and how is it different from berberine?
- Berberine timing in human studies
- Berberine and blood sugar: what trials measured
- Berberine amounts on US supplement labels
- Berberine and cholesterol: what studies measured
- Berberine drug interactions: which combinations were tested in people?
Sources
- Petrangolini G et al. Development of an innovative berberine food-grade formulation with an ameliorated absorption: in vitro evidence confirmed by healthy human volunteers pharmacokinetic study. Evidence-Based Complementary and Alternative Medicine, 2021:7563889. https://doi.org/10.1155/2021/7563889 ↩
- Rondanelli M et al. Berberine phospholipid is an effective insulin sensitizer and improves metabolic and hormonal disorders in women with polycystic ovary syndrome. Nutrients, 2021;13(10):3665. https://doi.org/10.3390/nu13103665 ↩
- Murakami T, Bodor E, Bodor N. Approaching strategy to increase the oral bioavailability of berberine, a quaternary ammonium isoquinoline alkaloid: Part 1. Expert Opinion on Drug Metabolism & Toxicology, 2023;19(3):129–137. https://doi.org/10.1080/17425255.2023.2203857 ↩
You may quote, republish or translate this article under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/): credit "Verateca", link to this page and indicate changes, including translations. Quotes from NIH, FDA and other sources, label texts and prices are not covered by this license.